Concepedia

Zhi-Ming Shao

ZS

Statistics

Publications

3

Citations

689

H-Index

3

Active since

2022

Affiliations

Harvard University(Current)

German Breast group

University of Ulsan

European Institute of Oncology

Medical University of Vienna

Zhi-Ming Shao is an author at Harvard University specializing in oncology, breast oncology, and adjuvant therapy.

Publications per year

2022–2025

3

Publications

3

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

Giuseppe Curigliano, Harold J. Burstein, Michael Gnant et al. · Annals of Oncology · 2023 · 221 citations · Full text

Medicine, Oncology, Surgery +17

LBA21 First-line (1L) datopotamab deruxtecan (Dato-DXd) vs chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (mTNBC) for whom immunotherapy was not an option: Primary results from the randomised, phase III TROPION-Breast02 trial

R. Dent, Zhi-Ming Shao, P. Schmid et al. · Annals of Oncology · 2025 · 21 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

1–3 of 3